Sanofi announced today that its Q3 2024 Aide mémoire is available on the "Investors" page of the company's website: ...

EADV: New data reinforce Sanofi’s innovative approach and leadership across immune-mediated skin diseases 24 abstracts for Dupixent, including 4 oral presentations, highlight impact of ...

Dupixent recommended for EU approval by the CHMP to treat eosinophilic esophagitis in children as young as 1 year old Recommendation based on a phase 3 study showing a significantly ...

Bien que le phénomène de l’aggravation associée à l’inflammation neuroinflammatoire dans la sclérose en plaques soit largement reconnu par la communauté médicale, il reste encore beaucoup à faire pour ...

The phenomenon of smoldering-associated worsening in multiple sclerosis has been widely accepted by the medical community, yet much work is needed to fully integrate it into clinical practice.

L’hémophilie est une affection rare, héréditaire, à vie dans laquelle le sang d’une personne ne coagule pas correctement en raison d’un manque de protéines appelées facteurs de coagulation. Par ...

Sanofi, RadioMedix, and Orano Med announce licensing agreement on next-generation radioligand medicine for rare cancers Paris, France, and Houston, Texas, ...

Hemophilia can affect nearly every aspect of a person’s life, but these daily impacts are often overlooked, and current solutions rarely go beyond medical care. Sanofi is committed to working with the ...

Pooled results from the BOREAS and NOTUS studies show meaningful clinical benefit with 31% reduction in exacerbations along with lung function improvement Data from these two phase 3 studies supported ...

At Sanofi, we’re proud to be premium partner of Paris 2024. Like Olympians and Paralympians, we spend every day challenging ourselves and each other to be better, go further, and to never, ever settle ...

For several years, Sanofi has been implementing its Planet care strategy, aiming for net zero greenhouse gas emissions across all scopes by 2045, with an intermediate carbon neutrality milestone in ...

Depuis plusieurs années, Sanofi met en œuvre sa stratégie Planet Care, qui vise zéro émissions nettes de gaz à effet de serre (GES) sur tous les périmètres d'ici 2045, avec un objectif intermédiaire ...